FDA on Morcellation

MORCELLATORANDCANCER.COM THE FDA ON MORCELLATION April, 2014 - FDA health advisory panel concludes that there is insufficient evidence to pull the morcellators from the market completely. July, 2014 August, 2014 FDA makes a safety communication relating to morcellation cancer that discourages doctors from using morcellators in hysterectomy and fibroid removal surgeries Columbia University College of Physicians and Surgeons determines the rate of uterine malignancy in women undergoing surgeries using a power morcellator were much greater than previously reported. Two U.S. Senators write a letter to the Commissioner of the FDA urging that they request other manufacturers to withdraw their equipment from the market until further risk assessments can be made. Johnson & Johnson made the decision to voluntarily withdraw all of their power morcellation devices from the market. Balkin Law Group 2014